index - Myopathies inflammatoires & thérapies innovantes ciblées

Dernières publications

Chiffres clés

123 Publications avec texte intégral

Open Access

53 %

Mots clés

Case reports Antibodies AAV humoral immunity B-lymphocyte Antibody responses Anti-synthetase syndrome B cell homeostasis Auto-antibodies Cytokines Multidisciplinarity Biopsy Agalsidase Anti-IgE IgG Biomarker Adjudication Antisynthétase AAV Female Adeno-associated vector Adolescence Anti-interleukin-6 Adeno-associated virus vector Auto‐antibodies DM Interstitial lung disease Systems biology Autoimmune diseases Deep immune profiling Arthritis Humans Anti-drug antibodies AAV vectors Acute Kidney Injury/epidemiology/etiology Active Acid-alpha-glucosidase Amyotrophic lateral sclerosis Male Data integration Animals Dermatomyositis Anticorps spécifique des myosites Polymyositis Inflammatory myopathy Myopathy Auto-immunité Adeno-associated virus Aged Inflammation Skeletal muscle Sphingosine-1-phosphate Autoantibody Myositis Aldosterone Anémie hémolytique Middle Aged Myositis and muscle disease Mass cytometry Gene therapy Muscle COVID-19 Analyses multidimensionnelles Dependovirus/genetics/immunology Anti-Mi2 Cardio-oncology Biomarqueurs IMNM Prognosis Outcome measures Immune checkpoint inhibitors AAV vector Autoimmunity Aldostérone Adult Antisynthetase syndrome Fabry disease Interferon Antiphospholipid syndrome Anticorps anti-agalsidase Anti‐mitochondrial antibodies Inclusion body myositis Cancer AAV antibody Antisynthetase Pharmacology Machine learning Myocarditis Anti-agalsidase antibodies Inborn errors of metabolism Autoantibodies Assisted communication devices Abnormal movement Bioelectrical impedance analysis Immunotherapy Amyotrophy IBM Adverse drug reactions Idiopathic inflammatory myopathies Anti-MDA5 autoantibodies Biomarkers Lysosomal storage diseases